GeneDx Holdings Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

77.78

+0.93 (1.21%)

At close: Mar 13, 2026, 4:00 PM EDT

78.00

+0.22 (0.28%)

After-hours: Mar 13, 2026, 7:56 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Gene Dx	423.09M	302.29M	194.38M	122.23M	-
Gene Dx Growth	39.96%	55.52%	59.02%	-	-
Legacy Sema4	-	3.16M	8.19M	112.46M	212.20M
Legacy Sema4 Growth	-	-61.45%	-92.72%	-47.00%	18.33%
Fabric Genomics and Legacy Sema4	4.45M	-	-	-	-
Total	427.54M	305.45M	202.57M	234.69M	212.20M
Total Growth	39.97%	50.79%	-13.69%	10.60%	18.33%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	427.54M	305.45M	202.57M	234.69M	212.20M
United States Growth	39.97%	50.79%	-13.69%	10.60%	18.33%
Total	427.54M	305.45M	202.57M	234.69M	212.20M
Total Growth	39.97%	50.79%	-13.69%	10.60%	18.33%

Source: S&P Global Market Intelligence.